ATTBF - Abattis Bioceuticals Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.17
+0.01 (+4.94%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.16
Open0.17
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.16 - 0.17
52 Week Range0.05 - 0.74
Volume999,534
Avg. Volume1,228,335
Market Cap62.781M
Beta2.92
PE Ratio (TTM)N/A
EPS (TTM)-0.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    Abattis Signs Agreement with Cannamedix to Support the Development and Commercialization of CBD-infused Natural Health Products

    Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Cannamedix Inc. (“Cannamedix”) to provide Cannamedix with, among other things, pesticide-free cannabinoid-containing oils, research and development, analytical and regulatory services and access to Abattis’s distribution and marketing channels to support the development and commercialization of new CBD-infused nutraceuticals and natural health products. Cannamedix is a Calgary-based healthcare provider focused on the use of traditional and alternative therapies to address health conditions, from pain management to integrative cancer care. Pursuant to the LOI, Abattis and Cannamedix have agreed to negotiate in good faith the terms of a definitive agreement respecting the terms of their partnership.

  • GlobeNewswire5 days ago

    Abattis Completes its Fully Vertically Integrated Downstream Cannabis Business -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Vancouver, BC based Abattis Bioceuticals Corp.'s (ATT.CN) (ATT.CN) (ATT.CN) (ATTBF) intense focus on downstream cannabis products. For those thinking about longer-term implications, the writing is on the wall: cannabis flower will follow, at some point in the not too distant future, every other commodity and the prices will go down as supply meets and exceeds demand. Merchandise derived from cannabis, like oil extracts, edibles, nutraceuticals, and personal care products, are increasingly popular with consumers who are interested in the benefits of cannabis but not interested in smoking the flower.

  • GlobeNewswire6 days ago

    Abattis Adds Significant Strength to its Board and Leadership Team

    Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce the appointments of Kent McParland, Brazos Minshew, Shawn Balaghi and Jim Carter to the Company’s leadership team and Wolfgang Richter to its Board of Directors.

  • GlobeNewswire18 days ago

    Abattis to Commence Construction of Large-Scale Growing Facility on Gabriola Island

    Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce the engagement (the “Engagement”) of Ocean Pacific Contractors Ltd. (“Ocean Pacific”) for construction of a purpose-built 26,000 square foot cannabis production and extraction facility (the “Facility”) on Gabriola Island, British Columbia. The Engagement follows completion of the Company’s recent acquisition of the remaining 10% interest in Gabriola Green Farms Inc. (“Gabriola”) from CannaNUMUS Blockchain Inc., as a result of which Gabriola is now a wholly-owned subsidiary of the Company.

  • ACCESSWIRE20 days ago

    Abattis Bioceuticals is Combining Cannabis Products and Blockchain Tech

    NEW YORK, NY / ACCESSWIRE / May 1, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on Abattis Bioceuticals Corp. (ATTBF), a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. In March 2018 Abattis announced it has officially rebranded itself as a one-stop provider of downstream cannabis solutions for licensed producers and manufacturers of cannabinoid-containing products. The Company's new focus on downstream solutions reflects several of its recent acquisitions and the success of its fully integrated services offerings.

  • Newsfile21 days ago

    Abattis Completes Acquisition of Remaining Minority Interest in Gabriola Green Farms

    Vancouver, British Columbia--(Newsfile Corp. - April 30, 2018) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce, further to its news release dated April 18, 2018, that it has completed its acquisition of the remaining 10% ownership interest (the "Interest") in its subsidiary, Gabriola Green Farms Inc. ("Gabriola"). Abattis acquired the Interest from CannaNUMUS Blockchain Inc. for $2.5 million. Gabriola is now a wholly-owned subsidiary of the ...

  • Newsfilelast month

    Abattis Enters into Agreement to Acquire Remaining Minority Interest in Gabriola Green Farms

    Vancouver, British Columbia--(Newsfile Corp. - April 18, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it has entered into a share purchase agreement to acquire (the "Acquisition") the remaining 10% ownership interest in its subsidiary, Gabriola Green Farms Inc. ("Gabriola")."We are very happy to now own a 100% interest in Gabriola and integrate it as a wholly-owned subsidiary of Abattis. We believe that Gabriola's anticipated LP ...

  • Newsfilelast month

    Abattis Announces Board Changes

    Vancouver, British Columbia--(Newsfile Corp. - April 13, 2018) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Cameron Paddock to the Board of Directors. Mr. Paddock will fill the vacancy left by the resignation of Dr. Will Panenka who is leaving the Company to concentrate on other ventures."We are very excited have Mr. Paddock join our Board. On behalf of the Company, I would like ...

  • GlobeNewswire2 months ago

    Abattis Announces $8 Million Financing and Successfully Closes First Tranche of Financing

    NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. VANCOUVER, British Columbia, March 27, 2018-- Abattis Bioceuticals Corp. is pleased to announce that it is has cancelled its previously ...

  • Newsfile2 months ago

    Abattis Provides Correction to March 13, 2018 News Release

    Vancouver, British Columbia--(Newsfile Corp. - March 26, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") announces a correction to its news release dated March 13, 2018 (the "Release"). In the Release, Canadian Artesian Ice Ltd. ("Canadian Artesian") was described as being the bottlers of Clearly Canadian products. However, the Company has since been advised that Canadian Artesian are not the bottlers of Clearly Canadian products. About Abattis Bioceuticals Corp. Abattis ...

  • GlobeNewswire2 months ago

    Abattis Strengthens Regulatory Services Offerings through Partnership with dicentra

    VANCOUVER, British Columbia, March 19, 2018-- Abattis Bioceuticals Corp. is pleased to announce it has signed a letter of intent with dicentra Inc. to establish a regulatory services partnership under ...

  • PR Newswire2 months ago

    Abattis Signs LOI with Canadian Artesian Ice, Bottlers of Clearly Canadian Products, to Manufacture CBD-infused Mineral Water

    Abattis Bioceuticals Corp. (the "Company" or "Abattis ") (CSE:ATT) (ATTBF) is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Canadian Artesian Ice Ltd. ("Canadian Artesian") to provide Canadian Artesian with, among other things, THC- and pesticide-free cannabidiol ("CBD") isolate, research and development services, nanoencapsulation and nanoemulsification services, analytical and regulatory services and access to Abattis's distribution and marketing channels to support the development, scalability and commercialization of a CBD-infused water for Canadian Artesian. Canadian Artesian is a bottler of Premium artesian 7.8 pH mineral water, based in Nelson, British Columbia, and is the bottler of Clearly Canadian Artesian mineral water.

  • CNW Group2 months ago

    Abattis Signs LOI with Canadian Artesian Ice, Bottlers of Clearly Canadian products, to Manufacture CBD-infused Mineral Water

    Abattis Signs LOI with Canadian Artesian Ice, Bottlers of Clearly Canadian products, to Manufacture CBD-infused Mineral Water

  • GlobeNewswire2 months ago

    Abattis Completes Acquisition to Become a Full Suite Cannabis Company -- CFN Media

    SEATTLE, March 12, 2018-- CFN Media Group, the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Abattis Bioceuticals Corp. and it full ...

  • PR Newswire2 months ago

    Abattis Signs LOI With Kanabé to Provide a Full Suite of Downstream Cannabis Solutions to Their Premium Health and Wellness Products

    VANCOUVER, British Columbia, March 8, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce it has signed a letter of intent (the "LOI") with Kanabé Corp. ("Kanabé") to provide Kanabé with cannabinoids as well as formulation, manufacturing, analytical and regulatory services to support the development and commercialization of Kanabé's products. Kanabé is a Calgary-based manufacturer of various health and wellness products, including topicals, sublingual oils and other skin-care products. Pursuant to the LOI, Abattis and Kanabé have agreed to negotiate in good faith the terms of a definitive research services agreement respecting the terms of their partnership.

  • CNW Group2 months ago

    Abattis Signs LOI With Kanabé to Provide a Full Suite of Downstream Cannabis Solutions to Their Premium Health and Wellness Products

    Abattis Signs LOI With Kanabé to Provide a Full Suite of Downstream Cannabis Solutions to Their Premium Health and Wellness Products

  • GlobeNewswire2 months ago

    Abattis Rebrands as a Downstream Solutions Provider for the Cannabis Market

    VANCOUVER, British Columbia, March 06, 2018-- Abattis Bioceuticals Corp. is pleased to announce it has officially rebranded itself as a one-stop provider of downstream cannabis solutions for licensed producers ...

  • GlobeNewswire3 months ago

    Abattis Announces Successful Completion of Acquisition of Gabriola Green Farms

    VANCOUVER, British Columbia, March 02, 2018-- Abattis Bioceuticals Corp. is pleased to announce that, further to its news release dated February 27, 2018, it has completed its acquisition of a 90% ownership ...

  • Newsfile3 months ago

    Abattis Comments on Recent Market Activity

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis"), wishes to make the following statements regarding certain market activity surrounding the Company's common shares (the "Common Shares"). On February 27, 2018, the Company was notified by the OTC Markets about certain promotional activities in relation to the Common Shares, including certain newsletter emails. The Company engaged Awareness Marketing LLC on February 16, 2018, to ...

  • PR Newswire3 months ago

    Abattis Enters Into Definitive Agreement To Acquire Gabriola Green Farms

    Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (ATT.CN) (ATTBF) is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") to acquire (the "Acquisition") a 90% ownership interest in Gabriola Green Farms Inc. ("Gabriola"). Gabriola is a privately held British Columbia company that has applied for a license to produce (an "LP") under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of British Columbia. Gabriola Island has a consistent temperature and humidity level, which makes it well suited to greenhouse growing.

  • CNW Group3 months ago

    Abattis Enters Into Definitive Agreement to Acquire Gabriola Green Farms

    Abattis Enters Into Definitive Agreement to Acquire Gabriola Green Farms